Excess Length of Stay Attributable to Clostridium difficile Infection (CDI) in the Acute Care Setting: A Multistate Model

被引:19
作者
Stevens, Vanessa W. [1 ,2 ]
Khader, Karim [1 ,3 ]
Nelson, Richard E. [1 ,3 ]
Jones, Makoto [1 ,3 ]
Rubin, Michael A. [1 ,3 ]
Brown, Kevin A. [1 ,3 ]
Evans, Martin E. [4 ]
Greene, Tom [1 ,3 ]
Slade, Eric [5 ]
Samore, Matthew H. [1 ,3 ]
机构
[1] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA
[2] Univ Utah, Coll Pharm, Pharmacotherapy Outcomes Res Ctr, Salt Lake City, UT 84121 USA
[3] Univ Utah, Sch Med, Div Epidemiol, Salt Lake City, UT 84121 USA
[4] Natl Infect Dis Serv, Vet Hlth Adm, Methicillin Resistant Staphylococcus Aureus Multi, Lexington, KY USA
[5] VA Capitol Hlth Care Syst, Mental Illness Resource Educ & Clin Ctr, Baltimore, MD USA
关键词
RESISTANT STAPHYLOCOCCUS-AUREUS; TIME-DEPENDENT BIAS; NOSOCOMIAL INFECTION; HOSPITAL-ONSET; MORTALITY; STRAIN; EPIDEMIOLOGY; SURVEILLANCE; DISEASES; ADULTS;
D O I
10.1017/ice.2015.132
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BACKGROUND. Standard estimates of the impact of Clostridium difficile infections (CDI) on inpatient lengths of stay (LOS) may overstate inpatient care costs attributable to CDI. In this study, we used multistate modeling (MSM) of CDI timing to reduce bias in estimates of excess LOS. METHODS. A retrospective cohort study of all hospitalizations at any of 120 acute care facilities within the US Department of Veterans Affairs (VA) between 2005 and 2012 was conducted. We estimated the excess LOS attributable to CDI using an MSM to address time-dependent bias. Bootstrapping was used to generate 95% confidence intervals (CI). These estimates were compared to unadjusted differences in mean LOS for hospitalizations with and without CDI. RESULTS. During the study period, there were 3.96 million hospitalizations and 43,540 CDIs. A comparison of unadjusted means suggested an excess LOS of 14.0 days (19.4 vs 5.4 days). In contrast, the MSM estimated an attributable LOS of only 2.27 days (95% CI, 2.14-2.40). The excess LOS for mild-to-moderate CDI was 0.75 days (95% CI, 0.59-0.89), and for severe CDI, it was 4.11 days (95% CI, 3.90-4.32). Substantial variation across the Veteran Integrated Services Networks (VISN) was observed. CONCLUSIONS. CDI significantly contributes to LOS, but the magnitude of its estimated impact is smaller when methods are used that account for the time-varying nature of infection. The greatest impact on LOS occurred among patients with severe CDI. Significant geographic variability was observed. MSM is a useful tool for obtaining more accurate estimates of the inpatient care costs of CDI.
引用
收藏
页码:1024 / 1030
页数:7
相关论文
共 35 条
[1]  
Allignol A, 2011, J STAT SOFTW, V38, P1
[2]   PLAGUES - WHATS PAST IS PRESENT - THOUGHTS ON THE ORIGIN AND HISTORY OF NEW INFECTIOUS-DISEASES [J].
AMPEL, NM .
REVIEWS OF INFECTIOUS DISEASES, 1991, 13 (04) :658-665
[3]  
[Anonymous], HOSP EPIDEMIOLOGY IN
[4]   Clostridium difficile Surveillance: A Multicenter Comparison of LabID Events and Use of Standard Definitions [J].
Baier, Rosa ;
Morphis, Blake ;
Marsella, Maureen ;
Mermel, Leonard A. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2013, 34 (06) :653-655
[5]   The Time-Dependent Bias and its Effect on Extra Length of Stay due to Nosocomial Infection [J].
Barnett, Adrian G. ;
Beyersmann, Jan ;
Allignol, Arthur ;
Rosenthal, Victor D. ;
Graves, Nicholas ;
Wolkewitz, Martin .
VALUE IN HEALTH, 2011, 14 (02) :381-386
[6]   Using a Longitudinal Model to Estimate the Effect of Methicillin-resistant Staphylococcus aureus Infection on Length of Stay in an Intensive Care Unit [J].
Barnett, Adrian G. ;
Batra, Rahul ;
Graves, Nicholas ;
Edgeworth, Jonathan ;
Robotham, Julie ;
Cooper, Ben .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 170 (09) :1186-1194
[7]   Nosocomial Infection, Length of Stay, and Time-Dependent Bias [J].
Beyersmann, Jan ;
Kneib, Thomas ;
Schumacher, Martin ;
Gastmeier, Petra .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2009, 30 (03) :273-276
[8]   Derivation and validation of a simple, accurate and robust prediction rule for risk of mortality in patients with Clostridium difficile infection [J].
Butt, Emma ;
Foster, Jane A. H. ;
Keedwell, Edward ;
Bell, Julia E. A. ;
Titball, Richard W. ;
Bhangu, Aneel ;
Michell, Stephen L. ;
Sheridan, Ray .
BMC INFECTIOUS DISEASES, 2013, 13
[9]   Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007 [J].
Cheknis, Adam K. ;
Sambol, Susan P. ;
Davidson, David M. ;
Nagaro, Kristin J. ;
Mancini, Maria C. ;
Hidalgo-Arroyo, G. Aida ;
Brazier, Jon S. ;
Johnson, Stuart ;
Gerding, Dale N. .
ANAEROBE, 2009, 15 (06) :230-233
[10]   Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) [J].
Cohen, Stuart H. ;
Gerding, Dale N. ;
Johnson, Stuart ;
Kelly, Ciaran P. ;
Loo, Vivian G. ;
McDonald, L. Clifford ;
Pepin, Jacques ;
Wilcox, Mark H. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2010, 31 (05) :431-455